Jack Wanger
YOU?
Author Swipe
View article: International consensus on lung function testing during the COVID-19 pandemic and beyond
International consensus on lung function testing during the COVID-19 pandemic and beyond Open
Coronavirus disease 2019 (COVID-19) has negatively affected the delivery of respiratory diagnostic services across the world due to the potential risk of disease transmission during lung function testing. Community prevalence, reoccurrence…
View article: Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons Open
Measuring FVC decline in the clinic has an important role in monitoring disease progression in patients with IPF, but additional measures of disease progression should be considered along with FVC to facilitate decision-making about diseas…
View article: ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing Open
Recently, this international task force reported the general considerations for bronchial challenge testing and the performance of the methacholine challenge test, a “direct” airway challenge test. Here, the task force provides an updated …
View article: <i>D</i><sub>LCO</sub>: adjust for lung volume, standardised reporting and interpretation
<i>D</i><sub>LCO</sub>: adjust for lung volume, standardised reporting and interpretation Open
D.C. Johnson proposed that an adjustment of the predicted value for the diffusing capacity of the lung for carbon monoxide (DLCO) based on the measured and predicted lung volume be included in the report of DLCO test results. An interpreta…
View article: ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests Open
This international task force report updates general considerations for bronchial challenge testing and the performance of the methacholine challenge test. There are notable changes from prior recommendations in order to accommodate newer …
View article: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung
2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung Open
This document provides an update to the European Respiratory Society (ERS)/American Thoracic Society (ATS) technical standards for single-breath carbon monoxide uptake in the lung that was last updated in 2005. Although both D LCO (diffusi…
View article: Executive Summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung
Executive Summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung Open
This document summarises an update to the European Respiratory Society (ERS)/American Thoracic Society (ATS) technical standards for single-breath carbon monoxide uptake in the lung that was last updated in 2005. The full standards are als…
View article: FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis Open
FG-3019 is a fully human monoclonal antibody that interferes with the action of connective tissue growth factor, a central mediator in the pathogenesis of fibrosis. This open-label phase 2 trial evaluated the safety and efficacy of two dos…